---
title: 'Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for
  the Treatment of Diffuse Malignant Peritoneal Mesothelioma: A GRADE Approach for
  Evidence Evaluation and Recommendation'
date: '2024-11-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39609952/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241129173059&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: The Peritoneal Surface Oncology Group International (PSOGI) previously
  issued a recommendation endorsing cytoreductive surgery (CRS) and hyperthermic intraperitoneal
  chemotherapy (HIPEC) for treating diffuse malignant peritoneal mesothelioma (DMPM).
  However, broader acceptance of this approach, particularly within some segments
  of medical oncology, remains limited. To address this, PSOGI initiated a multisociety
  consensus effort, involving multidisciplinary International Societies, to ...
disable_comments: true
---
The Peritoneal Surface Oncology Group International (PSOGI) previously issued a recommendation endorsing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treating diffuse malignant peritoneal mesothelioma (DMPM). However, broader acceptance of this approach, particularly within some segments of medical oncology, remains limited. To address this, PSOGI initiated a multisociety consensus effort, involving multidisciplinary International Societies, to ...